Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.260
-0.110 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
2.270
+0.010 (0.44%)
After-hours: Dec 5, 2025, 4:10 PM EST
Anebulo Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -8.44 | -8.48 | -8.2 | -11.73 | -6.83 | -30.25 | |
| Other Amortization | 0.34 | 0.38 | 0.15 | - | - | - | |
| Stock-Based Compensation | 1.4 | 1.45 | 0.76 | 0.88 | 0.48 | 0.2 | |
| Other Operating Activities | - | - | - | - | - | 26.63 | |
| Change in Accounts Receivable | - | - | - | - | - | 0 | |
| Change in Accounts Payable | 0.36 | 0.07 | -0.38 | 0.15 | 0.27 | 0.11 | |
| Change in Other Net Operating Assets | 0.42 | 0.24 | -0.42 | 1.01 | 0.64 | -1.56 | |
| Operating Cash Flow | -5.93 | -6.35 | -8.09 | -9.68 | -5.44 | -4.87 | |
| Short-Term Debt Repaid | - | - | - | - | - | -0.2 | |
| Total Debt Repaid | - | - | - | - | - | -0.2 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.2 | |
| Issuance of Common Stock | 15 | 15 | - | 6.7 | - | 20.6 | |
| Other Financing Activities | -0.12 | -0.12 | -0.06 | -0.32 | - | 1.43 | |
| Financing Cash Flow | 14.88 | 14.88 | -0.06 | 6.38 | - | 21.83 | |
| Net Cash Flow | 8.95 | 8.53 | -8.15 | -3.3 | -5.44 | 16.96 | |
| Cash Interest Paid | - | - | - | - | - | 0.01 | |
| Levered Free Cash Flow | -3.37 | -3.87 | -5.18 | -5.32 | -2.88 | -3.51 | |
| Unlevered Free Cash Flow | -3.5 | -4.01 | -5.23 | -5.32 | -2.88 | -3.5 | |
| Change in Working Capital | 0.77 | 0.31 | -0.8 | 1.16 | 0.91 | -1.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.